Reference results for Lumiliximab from Search.com.

Lumiliximab - Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Lumiliximab

Lumiliximab is a monoclonal antibody that targets CD23. It acts as an immunomodulator [1] and, as of October 2009, it is being investigated in Phase I and II clinical ...

CLL Topics: Lumiliximab - The Next Drug in CLL?

www.clltopics.org/MOABs/Lumi.htm

Lumiliximab: The Next Drug in CLL? Date: March 6, 2007. by Chaya Venkat. A New ‘Babe’ in Town. Related Article: IDEC 152. Anytime there is a new monoclonal ...

Anti-CD23 monoclonal antibody, lumiliximab, inhibited ...

www.ncbi.nlm.nih.gov/pubmed/16210051

1. J Allergy Clin Immunol. 2005 Oct;116(4):780-8. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T ...

Lumiliximab in Combination With FCR in Subjects With ...

https://clinicaltrials.gov/ct2/show/NCT00103558

Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)

lumiliximab - Wiktionary

https://en.wiktionary.org/wiki/lumiliximab

lumiliximab ‎(uncountable) Wikipedia has an article on: lumiliximab. Wikipedia. A chimeric monoclonal antibody being investigated for the treatment of chronic ...

Anti-CD23 monoclonal antibody, lumiliximab, inhibited ...

www.sciencedirect.com/science/article/pii/S0091674905016441

CD23 plays a role in the regulation of IgE production and allergy-induced immune and inflammatory responses. A novel anti-CD23 monoclonal antibody, lumiliximab,

Talk:Lumiliximab - Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Talk:Lumiliximab

This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to ...

Clinical Trials and Observations: Phase 1/2 study of ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2810983

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Lumiliximab With Fludarabine, Cyclophosphamide, and ...

https://clinicaltrials.gov/ct2/show/NCT00391066

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (LUCID)

Galiximab - Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Galiximab

Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials. [1]